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Recently, Chadwick and Oppenheim published guide- 
lines aimed at the control of glycopeptide-resistant 
enterococci (GRE) [l]. The rising incidence and 
clinical implications of GRE intensify the importance 
of such control measures but what is needed in theory 
and what actually occurs in clinical practice are some- 
times widely different. 
Although the guidelines proposed by Chadwick 
and Oppenheim and published in a recent issue of this 
journal [I] are quite comprehensive, they need to be 
adapted to individual use and extended in detail, with 
advice about the flagging of carriers, post-isolation 
screening (to determine GRE eradication), and 
eradication treatment, for example. We agree with 
Chadwick and Oppenheim that screening healthcare 
workers (HCW) is not relevant. In a recent study, Endtz 
et al [2] found the prevalence of fecal GRE carriership 
to be equal (at 2%) in high-risk, hospitalized and 
community-based patients in The Netherlands. In 
another study that we performed among healthy elderly 
subjects, we found GRE to be present in the feces of 
9% of all cases [3]. These observations, together with 
the uncertainty concerning whether and how to 
eradicate GRE, imply that screening of H C W  might 
be helpful in studying the epidemiology of GRE but 
does not need to be part of routine infection control 
measures. 
Despite referring to it as handwashing, Chadwick 
and Oppenheim [l] mentioned the superiority of the 
disinfection process against enterococcal contamina- 
tion. We strongly feel that handwashing in general is 
not only less effective than hand-disinfection but, 
furthermore, a waste of the time of the scarce work- 
force [4]. Infection control guidelines for GRE should 
emphasize the importance of disinfection. 
For patients who are colonized with GRE, we 
advise isolation in all cases. The risk management 
approach based on the absence or presence of diarrhea, 
suggested by Chadwick and Oppenheim [l], seems 
very logical, especially given the sparse possibilities of 
isolation in some hospitals, but we decided to isolate all 
patients regardless of whether or not at the time of 
GRE isolation a diarrhea was present. This simpler 
approach may include some patients with a lower 
potential for dispersion but in our experience it 
prevents misunderstandings and ensures compliance 
with isolation guidelines. 
As part of an ongoing European prevalence study 
we have surveyed 53 European hospitals in 27 different 
countries with regard to the infection control guide- 
lines applied for GRE and MRSA. The data requested 
included the type of hospital, census figures such as the 
total number of beds and healthcare workers (nurses 
and doctors), and the first occurrence and observed 
prevalence of GRE. The last part of the questionnaire 
included detailed questions on infection control guide- 
lines and measures. 
Of  the 53 questionnaires issued, 38 evaluable forms 
were returned. Responses were obtained from Austria 
(2), Belgium (l), Bulgaria (l), Croatia (I), the Czech 
Republic (I), Denmark (3),  Finland (I), France (I), 
Germany (3) ,  Hungary (2), Israel (2), Italy (2), Latvia 
(l), The  Netherlands (3),  Norway (I), Poland (I), 
Russia (I) ,  Slovenia (l), Spain (2) ,  Sweden (3), 
Switzerland (I), Turkey (1) and the UK (3). With 
the exception of five hospitals (13%), all hospitals 
were university/teaching hospitals. The number of 
beds varied from 130 to 3100 (mean 992); the number 
of healthcare workers varied from 82 to 4000 (mean 
1634). The HCWlpatient ratio ranged from 0.63 
(Russia) to 3.64 (Sweden), with a mean of 1.65 
healthcare workers per patient. 
GKE occurrence was reported by 19 (50%) 
hospitals (Table 1). Two university hospitals reported 
their first GRE occurrence in 1993, but general 
hospitals did not encounter GRE until 1995. In 1996, 
19 of the hospitals encountered GRE and obtained 
isolates from 102 patients in total (mean 2.7 per 
hospital) (Table 1). In most hospitals the estimated 
GRE prevalence during 1996 was below 1% of 
patients; only three hospitals reported higher pre- 
valences, of 1%, 2% and 3%, respectively. During 1996, 
five hospitals each isolated GRE from 214 patients but 
only one of these hospitals (Germany) reported the 
occurrence of an outbreak during that same year. In 
total, 19 hospitals in 17 different countries (Austria, 
Bulgaria, Croatia, the Czech Republic, Denmark (2), 
Hungary (2), Latvia, The Netherlands, Norway, Poland, 
Russia, Slovenia, Spain, Sweden, Switzerland, Turkey 
and the UK) reported that they had not yet encoun- 
tered GRE. 
Overall, 14 (37%) of the hospitals reported having 
written guidelines for the control of GRE; 10 (53%) 
of the hospitals with previous occurrence of GRE 
compared to four (21%) of all hospitals which had not 
yet isolated GRE. Differences in the guidelined 
infection control measures are given in Table 2. Gloves 
and hand-disinfection were employed in all hospitals. 
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Table 1 Characteristics of 22 European hospitals which isolated GRE 
Year of Number of patients Estimated GKE 
Hospital first GRE with GRE detected prevalence during HCW/patient 
Country type occurrence during 1996 1996 (“A) ratio 
Austria University 1996 1 <1 0.86 
Belgium University 1993 3 <1 1.78 
Denmark General 1996 1 <1 1 .oo 
Finland University 1996 1 <1 1.94 
France University 1996 2 < I  1 .5n 
Germany University 1995 3 < l  1.20 
University 1996 28 Unknown Unknown 
Umversity 1996 2 <1 Unknown 
Israel University 1994 0 0 2.43 
Italy University 1995 15 3 1.05 
University 1994 2 <1 Unknown 
The Netherlands University 1996 2 1 2.04 
University 1995 15 2 1.63 
Spain University 1994 7 1 2.53 
Sweden General 1995 2 <1 2.33 
University 1995 0 <1 2.26 
UK University 1995 4 <1 Unknown 
University 1994 1 <1 2.91 
University 1993 14 Unknown 0.78 
GRE’glycopeptide-resistant enterococci; HCW=healthcare workers (doctors and nurses). 
Some respondents, from hospitals without guidelines, 
mentioned handwashing rather than hand-disinfection. 
In most locations, guidelines were aimed at both 
infected and colonized patients. 
The results of our survey indicate that GRE had 
spread to affect about half of Europe’s university/ 
teaching hospitals by the end of 1996. Nevertheless, 
only one-third of the surveyed hospitals had written 
guidelines for GRE control. Thus, it seems that much 
remains to be done in introducing the available guide- 
lines into clinical practice. 
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Table 2 GRE measures as applied by European hospitals 
with existing isolation guidelines 
Measure 
Applied by number 
of all 14 hospitals 
Isolation of patient 
Use of single room 
Use of gowns 
Use of gloves 





Active search for carriers 
Use guidelines: 
For infected and colonized patients 
For infected patients only 
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